Pharmaceutical News

Synthon today announced that it has successfully concluded a phase I clinical trial for trastuzumab, a biosimilar to Herceptin © , for treatment of breast cancer and gastric cancer.

Abbott has selected AbbVie [pronounced Abb-vee] to be name of new, independent research-based pharmaceutical company which is expected to be launched by the end of 2012.

Karen Tibbals worked for many years as a market researcher for some large pharma companies.  She recently left pharma and marketing research to enter divinity school.